Sera Prognostics, Inc. (SERA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.11
+3.94%
Mkt Cap $72.62M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.50
Range $5.00 – $6.00
Implied Upside
+160.7%
Consensus $5.50 vs current $2.11